JANSSEN’s ERGAMISOL (LEVAMISOLE) APPROVED AS ADJUVANT IN DUKES' C COLON CANCER WITH 5-FU AFTER 7-1/2 MONTH NDA REVIEW; PRODUCT LAUNCH IS UNDERWAY

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".